Loading clinical trials...

Study of FORTEO Use in Subjects in the Community Setting | Clinical Trials | Clareo Health

COMPLETEDNCT01078805

Study of FORTEO Use in Subjects in the Community Setting

The purpose of this study is to evaluate the long-term effectiveness, safety, and tolerability of FORTEO in a larger, more diverse "real world" population than studied in clinical trials

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

NCT07027306 · Osteoporotic Fractures, Osteoporosis

RECRUITINGPhase 4

Combined Anabolic Therapy

NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis

RECRUITINGPhase 4

GLP-1R Actions on Muscle and the Skeleton

NCT07154719 · Musculoskeletal Abnormalities, Obesity, and more

RECRUITING

A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures

NCT06449742 · Vertebral Fracture, Osteoporosis

RECRUITING

Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging

NCT07474571 · Osteoarthitis, Osteoporosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 26, 2012Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment4,167

Start dateAug 2003

Last updatedJun 26, 2012

Condition

Osteoporosis

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Lakewood, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of FORTEO Use in Subjects in the Community Setting

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Combined Anabolic Therapy

GLP-1R Actions on Muscle and the Skeleton

A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures

Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging

Trial snapshot

Condition

Locations shown

For caregivers